Jeff Aronin has been very successful in leading many pharmaceutical companies with finding novel treatments for patients and their families. His dedication to continuously assist in the progress in providing vital medicines to families who need it the most is highly commendable. His partnership with Paragon is eagerly anticipated with further studies of biosciences in creation for newer medicines that focuses on some of the more rare diseases that do not affect the greater population. His strong work ethic and shared belief in Paragon philosophy of helping as many patients as possible, even ones who generally are overlooked due to the rarity of their illness has led him to receive several accolades and honors during his career even before the collaboration with Paragon and other start up pharmaceutical he has had a huge part in. Some of his most recent awards includes the Weizmann Leadership Award, The Frederic A. Gibbs Discovery Award and even the Deal Of The Year accolade from the Buyouts in 2010. He was also one of the Entrepreneur of the year finalist by Ernst & Young within his geographical area in 2006.
Jeff Aronin has supported many companies all over the globe throughout the years, constantly showcasing his passion in developing and maintaining the next generation of healthcare leaders. Some of the organizations Jeff has been known to provide his expertise and support to are the Juvenile Diabetes Research, the prominent Susan G. Komen organization and Cystic Fibrosis Foundation, just to name a few. He is also the leading participate in many of the start up companies that are in the inception stages in Chicago. It’s very interesting to see what plans Jeff has in store for his future endeavors with leading, educating, and improving lives in the bioscience industry with finding innovative ways to bring essential medicines to many individuals and their families.
Jorge Moll is the current founder and head of D’Or Institute of Research and Education where a long time ago he had an epiphany, and a dream that grew into a passion to help his country achieve greater levels of education, greater levels of healthcare, and greater levels of world class research. The dream and passion he has is something that he has always had even since his youth, and with his expertise and years of history working in the medical field receiving his MD in neuroscience from the Federal University of Rio de Janeiro in Brazil he also completed his residency to become a full fledged neuroscientist. He also later at Sao Paulo University received his PhD in Experimental Pathophysiology.
The way that Jorge Moll is able to spread his dream and his vision to other people is by keeping productive in his day-to-day routines which consist of meetings with a variety of individuals over a variety of topics. Jorge Moll speaks with a large number of a diverse group of people that in compass many different organizations and fields and levels of expertise. A list of types of people that Jorge Moll meets with are students, associates, scientists, researchers, entrepreneurs, and many more and he believes that it is truly a key to have a diverse group of individuals to meet with as the exchange of ideas and the level of communication will allow for or brilliant revelation to become a reality.
That very ideas day he has use that become a reality are sometimes the ones that come from other people and the ideas that he has are constant in many and with so many ideas it can become extremely difficult to decide which is a good idea to invest in and which one should be dropped and no longer look at. He has a tendency also to choose those of which he believes can easily be converted into a measurable action plan that allows for multiple hands to invest time and energy in making it happen. He also has a strong interest in the trend and evolution of cognitive systems such as artificial intelligence and the possibility of machines and the brain working together to develop regenerative medicine and gene therapy. Over all Jorge Moll is someone who is consistently coming out with brilliant ideas with collaborative help from associates hoping to use neuroscience and technology to greater humanity.